Wednesday, August 24, 2022 7:41:59 PM
OTCShotCaller
Bullish
08:21 AM
$RGBP
- The thing I like about Dr Koos is he's a proven genius, scientific leader, and a no bullshit kind of guy who means business ALL of which is PROVEN by his track record over the past 18 months based on his epic number of SEC filings that by far exceeds any company trading on the major exchanges.
IMO, he's your classic BIG PHARMA CEO who UNLIKE BP CEO's happens to be an accomplished scientist with an extraordinary track record of developing Disruptive Biotechnology Patents that very clearly have the capacity to cure cancer. Fact is, we're on the front end of participating in ushering in a Paradigm Shift in Modern Medicine for cancer & infectious disease cure & prevention. This is what we're looking at!
Then the question of course rises, "then why is this company still on the OTC in the penny & sub penny range? Good question, and the answer to that is 1) due to the Crooked MMs & Criminal Naked Short Sellers; 2) limited recognition by the scientific community which is in progress.
Bullish
08:21 AM
$RGBP
- The thing I like about Dr Koos is he's a proven genius, scientific leader, and a no bullshit kind of guy who means business ALL of which is PROVEN by his track record over the past 18 months based on his epic number of SEC filings that by far exceeds any company trading on the major exchanges.
IMO, he's your classic BIG PHARMA CEO who UNLIKE BP CEO's happens to be an accomplished scientist with an extraordinary track record of developing Disruptive Biotechnology Patents that very clearly have the capacity to cure cancer. Fact is, we're on the front end of participating in ushering in a Paradigm Shift in Modern Medicine for cancer & infectious disease cure & prevention. This is what we're looking at!
Then the question of course rises, "then why is this company still on the OTC in the penny & sub penny range? Good question, and the answer to that is 1) due to the Crooked MMs & Criminal Naked Short Sellers; 2) limited recognition by the scientific community which is in progress.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
